337 related articles for article (PubMed ID: 24009430)
1. AKT-independent PI3-K signaling in cancer - emerging role for SGK3.
Bruhn MA; Pearson RB; Hannan RD; Sheppard KE
Cancer Manag Res; 2013; 5():281-92. PubMed ID: 24009430
[TBL] [Abstract][Full Text] [Related]
2. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.
Gonzalez-Robayna IJ; Falender AE; Ochsner S; Firestone GL; Richards JS
Mol Endocrinol; 2000 Aug; 14(8):1283-300. PubMed ID: 10935551
[TBL] [Abstract][Full Text] [Related]
3. Regulation of KCNE1-dependent K(+) current by the serum and glucocorticoid-inducible kinase (SGK) isoforms.
Embark HM; Böhmer C; Vallon V; Luft F; Lang F
Pflugers Arch; 2003 Feb; 445(5):601-6. PubMed ID: 12634932
[TBL] [Abstract][Full Text] [Related]
4. Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader.
Tovell H; Testa A; Zhou H; Shpiro N; Crafter C; Ciulli A; Alessi DR
ACS Chem Biol; 2019 Sep; 14(9):2024-2034. PubMed ID: 31461270
[TBL] [Abstract][Full Text] [Related]
5. SGK3 (CISK) may induce tumor angiogenesis (Hypothesis).
Hou M; Lai Y; He S; He W; Shen H; Ke Z
Oncol Lett; 2015 Jul; 10(1):23-26. PubMed ID: 26170971
[TBL] [Abstract][Full Text] [Related]
6. Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention.
Basnet R; Gong GQ; Li C; Wang MW
Acta Pharm Sin B; 2018 Sep; 8(5):767-771. PubMed ID: 30245963
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase.
Kobayashi T; Deak M; Morrice N; Cohen P
Biochem J; 1999 Nov; 344 Pt 1(Pt 1):189-97. PubMed ID: 10548550
[TBL] [Abstract][Full Text] [Related]
8. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway.
Rong R; He Q; Liu Y; Sheikh MS; Huang Y
Oncogene; 2002 Feb; 21(7):1062-70. PubMed ID: 11850823
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition effect of active fraction from clove on PI3K/Akt/mTOR signaling pathway to induce apoptosis of human colon cancer HCT116 cells].
Zhao G; Zhang D; Yang XH; Li XF; Liu MH
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1197-1204. PubMed ID: 33787115
[TBL] [Abstract][Full Text] [Related]
10. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
O' Neill C
Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.
Shrivastava S; Kulkarni P; Thummuri D; Jeengar MK; Naidu VG; Alvala M; Redddy GB; Ramakrishna S
Apoptosis; 2014 Jul; 19(7):1148-64. PubMed ID: 24729100
[TBL] [Abstract][Full Text] [Related]
12. Second AKT: the rise of SGK in cancer signalling.
Bruhn MA; Pearson RB; Hannan RD; Sheppard KE
Growth Factors; 2010 Dec; 28(6):394-408. PubMed ID: 20919962
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways.
Liu SL; Lin X; Shi DY; Cheng J; Wu CQ; Zhang YD
Arch Biochem Biophys; 2002 Oct; 406(2):173-82. PubMed ID: 12361705
[TBL] [Abstract][Full Text] [Related]
14. The PI3-K/AKT-pathway and radiation resistance mechanisms in non-small cell lung cancer.
Schuurbiers OC; Kaanders JH; van der Heijden HF; Dekhuijzen RP; Oyen WJ; Bussink J
J Thorac Oncol; 2009 Jun; 4(6):761-7. PubMed ID: 19404218
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of HERG channels by the serum and glucocorticoid inducible kinase isoform SGK3.
Maier G; Palmada M; Rajamanickam J; Shumilina E; Böhmer C; Lang F
Cell Physiol Biochem; 2006; 18(4-5):177-86. PubMed ID: 17167223
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase.
Gorin Y; Kim NH; Feliers D; Bhandari B; Choudhury GG; Abboud HE
FASEB J; 2001 Sep; 15(11):1909-20. PubMed ID: 11532971
[TBL] [Abstract][Full Text] [Related]
17. Loss of serum and glucocorticoid-regulated kinase 3 (SGK3) does not affect proliferation and survival of multiple myeloma cell lines.
Hausmann S; Brandt E; Köchel C; Einsele H; Bargou RC; Seggewiss-Bernhardt R; Stühmer T
PLoS One; 2015; 10(4):e0122689. PubMed ID: 25837824
[TBL] [Abstract][Full Text] [Related]
18. Phosphoproteomics reveals that the hVPS34 regulated SGK3 kinase specifically phosphorylates endosomal proteins including Syntaxin-7, Syntaxin-12, RFIP4 and WDR44.
Malik N; Nirujogi RS; Peltier J; Macartney T; Wightman M; Prescott AR; Gourlay R; Trost M; Alessi DR; Karapetsas A
Biochem J; 2019 Oct; 476(20):3081-3107. PubMed ID: 31665227
[TBL] [Abstract][Full Text] [Related]
19. Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer.
Sahoo S; Brickley DR; Kocherginsky M; Conzen SD
Eur J Cancer; 2005 Nov; 41(17):2754-9. PubMed ID: 16246546
[TBL] [Abstract][Full Text] [Related]
20. Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds.
Gong GQ; Wang K; Dai XC; Zhou Y; Basnet R; Chen Y; Yang DH; Lee WJ; Buchanan CM; Flanagan JU; Shepherd PR; Chen Y; Wang MW
Acta Pharmacol Sin; 2018 Dec; 39(12):1902-1912. PubMed ID: 30038340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
